Amadeus IT Group (OTCMKTS:AMADY – Get Rating) and Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Rating) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.
Volatility and Risk
Amadeus IT Group has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Zealand Pharma A/S has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Amadeus IT…